Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Bone Therapeutics SA
  6. Summary
    BOTHE   BE0974280126

BONE THERAPEUTICS SA

(BOTHE)
  Report
Real-time Quote. Real-time Euronext Bruxelles - 06/11 11:35:07 am
2.36 EUR   -0.84%
06/10BONE THERAPEUTICS  : announces Annual General Meeting results
AQ
06/10BONE THERAPEUTICS SA  : Proxy Statments
CO
05/26BONE THERAPEUTICS  : Provides First Quarter 2021 Business Update
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
2.285(c) 2.255(c) 2.26(c) 2.38(c) 2.36(c) Last
43 340 54 552 46 342 39 587 11 693 Volume
-0.22% -1.31% +0.22% +5.31% -0.84% Change
More quotes
Financials
Sales 2021 3,93 M 4,76 M 4,76 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 55,8 M 67,5 M 67,5 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 38,9 M 47,0 M 47,1 M
Capi. / Sales 2021 9,89x
Capi. / Sales 2022 0,70x
Nbr of Employees 30
Free-Float 85,1%
More Financials
Company
Bone Therapeutics SA is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopaedics and bone diseases. Bone Therapeutics' core technology is based on its allogeneic cell therapy platform (ALLOB) which uses a unique, proprietary approach to bone regeneration, which turns undifferentiated stem cells from healthy donors into bone-forming cells. These cells... 
Sector
Pharmaceuticals
Calendar
06/21Presentation
More about the company
All news about BONE THERAPEUTICS SA
06/10BONE THERAPEUTICS  : announces Annual General Meeting results
AQ
06/10BONE THERAPEUTICS SA  : Proxy Statments
CO
05/26BONE THERAPEUTICS  : Provides First Quarter 2021 Business Update
AQ
05/26BONE THERAPEUTICS SA  : 1st quarter results
CO
05/20BONE THERAPEUTICS  : to participate in upcoming conferences
AQ
05/07BONE THERAPEUTICS  : 5/7/21 - Bone Therapeutics to host Annual General Meeting o..
PU
05/07BONE THERAPEUTICS  : to host Annual General Meeting on 9 June 2021
AQ
04/29BONE THERAPEUTICS  : announces 2020 full year results
AQ
04/29BONE THERAPEUTICS SA  : Annual results
CO
04/29BONE THERAPEUTICS SA  : Annual Report
CO
03/30BONE THERAPEUTICS  : Appoints New Chief Scientific Officer
MT
03/30BONE THERAPEUTICS  : 3/30/21 - Bone Therapeutics appoints industry cell therapy ..
PU
03/30BONE THERAPEUTICS  : appoints industry cell therapy expert, Anthony Ting, PhD as..
AQ
03/17BONE THERAPEUTICS  : to present in M Vest LLC and Maxim Group LLC Emerging Growt..
AQ
02/10BONE THERAPEUTICS  : Notice of Extraordinary Shareholders Meeting on 26 February..
AQ
More news
News in other languages on BONE THERAPEUTICS SA
06/10BRUSSELS STOCK EXCHANGE : Brussel sluit hoger
06/10Brussel licht omhoog
06/10Brussel weet geen richting te kiezen
06/10Brusselse beurs fractioneel hoger geopend
06/10Aandeelhouders Bone Therapeutics keuren alle agendapunten goed
More news
Chart BONE THERAPEUTICS SA
Duration : Period :
Bone Therapeutics SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BONE THERAPEUTICS SA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price 5,50 €
Last Close Price 2,36 €
Spread / Highest target 133%
Spread / Average Target 133%
Spread / Lowest Target 133%
Managers and Directors
NameTitle
Miguel Forte Chief Executive Officer
Jean-Luc Vandebroek Chief Financial Officer & Executive Director
Baron Jean Stéphenne Chairman
Olivier Godeaux Chief Medical Officer
Benoit Moreaux Chief Scientific & Technology Officer
Sector and Competitors